Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.

Nearly 300 Burmese pythons were removed during a record-setting Florida Python Challenge this year, state wildlife officials said. Subscribe to read this story ad-free Get unlimited access to ad-free ...

Does Microsoft's search engine have what it takes to compete with the all-powerful Google? After testing Bing and Google side by side on basic search, news, shopping, AI features, and much more, we ...

Measuring binary star systems' basic properties has proved exceedingly difficult. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Breaking space ...

Jon covers artificial intelligence. He previously led CNET's home energy and utilities category, with a focus on energy-saving advice, thermostats, and heating and cooling. Jon has more than a decade ...

Stars are the fundamental building blocks of our universe. Most stars host planets, like our Sun hosts our solar system, and if you look more broadly, groups of stars make up huge structures such as ...

This week, I had to make one of the most difficult decisions of my career: saying goodbye to 20% of the team at Recursion. The process was extraordinarily painful, and the costs were heartbreakingly ...

Recursion said today it is eliminating approximately 20% of its workforce—about 160 jobs—in a restructuring the AI-based drug developer said reflects both its recently-pruned pipeline and the ...